August Troendle
Director Ejecutivo en MEDPACE HOLDINGS, INC. .
Fortuna: 2 100 M $ al 30/04/2024
Perfil
Fundador de Medpace Holdings, Inc. y Medpace, Inc., August James Troendle es una persona de negocios que ha estado al frente de 5 empresas diferentes y ocupa el cargo de presidente y director general de Medpace Holdings, Inc. y presidente y director general de Medpace, Inc., director general de Medpace Medical Device, Inc., director general de Medpace Germany GmbH y presidente de Medpace Research, Inc. (todas ellas filiales de Medpace Holdings, Inc.). El Dr. Troendle también forma parte del consejo de Symplmed Pharmaceuticals LLC, LIB Therapeutics LLC, CinRx Pharma LLC y Medpace UK Ltd. En su anterior carrera profesional fue Director Asociado Senior en Sandoz, Inc. y Oficial de Revisión Médica-División Metabólica en The FDA Alliance. Se doctoró en la Facultad de Medicina de la Universidad de Maryland.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MEDPACE HOLDINGS, INC.
17.39% | 28/05/2024 | 5 387 675 ( 17.39% ) | 2 100 M $ | 30/04/2024 |
Cargos activos de August Troendle
| Empresas | Cargo | Inicio |
|---|---|---|
| MEDPACE HOLDINGS, INC. | Director Ejecutivo | 01/07/1992 |
Medpace, Inc.
 Medpace, Inc. Miscellaneous Commercial ServicesCommercial Services Medpace, Inc. provides clinical research services to the pharmaceutical, biotech and medical industries. It offers clinical operations, medical writing, biometrics, regulatory affairs, quality assurance, imaging core lab medical device and risk based monitoring services. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH. | Director Ejecutivo | 01/07/1992 |
LIB Therapeutics LLC
 LIB Therapeutics LLC Pharmaceuticals: MajorHealth Technology LIB Therapeutics LLC is a pharmaceutical company that manufactures medicinal products. The private company is based in Wilmington, DE. The company was founded by Evan A. Stein, August James Troendle. David A. Cory has been the CEO of the company since 2023. | Fundador | 01/01/2015 |
CinRx Pharma LLC
 CinRx Pharma LLC Pharmaceuticals: MajorHealth Technology CinRx Pharma LLC develops biopharmaceutical products. It provides therapeutics in a novel way that meets the modern paradigm of drug development. The company was founded by Jonathan L. Isaacsohn in 2015 and is headquartered in Cincinnati, OH. | Presidente | 01/01/2015 |
Medpace Medical Device, Inc.
 Medpace Medical Device, Inc. Miscellaneous Commercial ServicesCommercial Services Medpace Medical Device, Inc. provides research and development services focusing on medical device clinical trials. The company is headquartered in Blaine, MN. | Director Ejecutivo | - |
Medpace UK Ltd.
 Medpace UK Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2005, Medpace UK Ltd. is a subsidiary of Medpace Holdings, Inc. The company is based in London, UK. The British company offers clinical pharmacology and laboratory services, which include central laboratory, bioanalytical, ECG core lab, and imaging core labs. | Director/Miembro de la Junta | 01/05/2007 |
Medpace Germany GmbH
 Medpace Germany GmbH Pharmaceuticals: MajorHealth Technology Part of Medpace Holdings, Inc., Medpace Germany GmbH is a company that manufactures medicine. The company is based in Munich, Germany. The company was founded in 2003. August James Troendle has been the CEO of the company since 2018. | Director Ejecutivo | 01/08/2018 |
Antiguos cargos conocidos de August Troendle.
| Empresas | Cargo | Fin |
|---|---|---|
| CINCOR PHARMA, INC. | Director/Miembro de la Junta | 01/11/2021 |
| COHERUS BIOSCIENCES, INC. | Director/Miembro de la Junta | 01/02/2018 |
| ░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formación de August Troendle.
| University of Maryland School of Medicine | Doctorate Degree |
| Boston University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| XENON PHARMACEUTICALS INC. | Health Technology |
| COHERUS BIOSCIENCES, INC. | Health Technology |
| MEDPACE HOLDINGS, INC. | Commercial Services |
| Empresas privadas | 11 |
|---|---|
Medpace, Inc.
Medpace, Inc. Miscellaneous Commercial ServicesCommercial Services Medpace, Inc. provides clinical research services to the pharmaceutical, biotech and medical industries. It offers clinical operations, medical writing, biometrics, regulatory affairs, quality assurance, imaging core lab medical device and risk based monitoring services. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH. | Commercial Services |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Health Technology |
| The FDA Alliance | |
Symplmed Pharmaceuticals LLC
 Symplmed Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Symplmed Pharmaceuticals LLC manufactures pharmaceutical products. The company was founded by Erik C. Emerson and Jeff Feldstein in 2013 and is headquartered in Cincinnati, OH. | Health Technology |
LIB Therapeutics LLC
LIB Therapeutics LLC Pharmaceuticals: MajorHealth Technology LIB Therapeutics LLC is a pharmaceutical company that manufactures medicinal products. The private company is based in Wilmington, DE. The company was founded by Evan A. Stein, August James Troendle. David A. Cory has been the CEO of the company since 2023. | Health Technology |
CinRx Pharma LLC
CinRx Pharma LLC Pharmaceuticals: MajorHealth Technology CinRx Pharma LLC develops biopharmaceutical products. It provides therapeutics in a novel way that meets the modern paradigm of drug development. The company was founded by Jonathan L. Isaacsohn in 2015 and is headquartered in Cincinnati, OH. | Health Technology |
Medpace Research, Inc.
 Medpace Research, Inc. Medical DistributorsDistribution Services Medpace Research, Inc. is a pharmaceutical company, which focuses on the development of therapeutics to treat kidney disease, an area of significant unmet medical need. The company was founded by Billy G. Hudson, J. Wesley Fox Ahmann and Tryggvason Karl on May 25, 2004 and is headquartered in Cincinnati, OH. | Distribution Services |
Medpace Medical Device, Inc.
Medpace Medical Device, Inc. Miscellaneous Commercial ServicesCommercial Services Medpace Medical Device, Inc. provides research and development services focusing on medical device clinical trials. The company is headquartered in Blaine, MN. | Commercial Services |
Medpace UK Ltd.
Medpace UK Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2005, Medpace UK Ltd. is a subsidiary of Medpace Holdings, Inc. The company is based in London, UK. The British company offers clinical pharmacology and laboratory services, which include central laboratory, bioanalytical, ECG core lab, and imaging core labs. | Commercial Services |
Medpace Germany GmbH
Medpace Germany GmbH Pharmaceuticals: MajorHealth Technology Part of Medpace Holdings, Inc., Medpace Germany GmbH is a company that manufactures medicine. The company is based in Munich, Germany. The company was founded in 2003. August James Troendle has been the CEO of the company since 2018. | Health Technology |
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA. | Health Technology |
- Bolsa de valores
- Insiders
- August Troendle
